131 related articles for article (PubMed ID: 6324457)
21. Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cells.
Epstein AL
J Virol; 1984 May; 50(2):372-9. PubMed ID: 6323737
[TBL] [Abstract][Full Text] [Related]
22. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
Pearson GR; Orr TW
J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
[TBL] [Abstract][Full Text] [Related]
23. Polypeptides of the Epstein-Barr virus membrane antigen complex.
Thorley-Lawson DA; Edson CM
J Virol; 1979 Nov; 32(2):458-67. PubMed ID: 228070
[TBL] [Abstract][Full Text] [Related]
24. Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence.
Ernberg I; Klein G; Kourilsky FM; Silvestre D
J Natl Cancer Inst; 1974 Jul; 53(1):61-5. PubMed ID: 4365906
[No Abstract] [Full Text] [Related]
25. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
[TBL] [Abstract][Full Text] [Related]
26. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
[TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clones.
Khyatti M; Patel PC; Menezes J
Int J Cancer; 1991 Jun; 48(4):591-7. PubMed ID: 1646179
[TBL] [Abstract][Full Text] [Related]
28. Structure of the Epstein-Barr virus nuclear antigen as probed with monoclonal antibodies.
Hearing JC; Lewis A; Levine AJ
Virology; 1985 Apr; 142(1):215-20. PubMed ID: 2997981
[TBL] [Abstract][Full Text] [Related]
29. Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells.
Thorley-Lawson DA
Cell; 1979 Jan; 16(1):33-42. PubMed ID: 217544
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.
Hoffman GJ; Lazarowitz SG; Hayward SD
Proc Natl Acad Sci U S A; 1980 May; 77(5):2979-83. PubMed ID: 6248876
[TBL] [Abstract][Full Text] [Related]
31. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
[TBL] [Abstract][Full Text] [Related]
32. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye.
Sairenji T; Hinuma Y
Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a 75-kDa Epstein-Barr virus capsid protein using a new monoclonal antibody H250.
Sanchez-Pinel A; Bernad J; Rives H; Icart J; Didier J
Res Virol; 1989; 140(6):531-43. PubMed ID: 2559442
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of Epstein-Barr virus membrane antigens defined with monoclonal antibodies.
Yokochi T; Clark EA; Kimura Y
Virology; 1986 Jan; 148(1):114-20. PubMed ID: 3002025
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel EBV-induced membrane glycoprotein of 43 kDa with H667 MAb.
Sanchez-Pinel A; Bernad J; Rives H; Lapchine L; Icart J; Didier J
Virology; 1991 Jan; 180(1):31-40. PubMed ID: 1845828
[TBL] [Abstract][Full Text] [Related]
36. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
Coker-Vann M; Dolin R
J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
[TBL] [Abstract][Full Text] [Related]
37. Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus.
Falk L; Deinhardt F; Nonoyama M; Wolfe LG; Bergholz C
Int J Cancer; 1976 Dec; 18(6):798-807. PubMed ID: 186420
[TBL] [Abstract][Full Text] [Related]
38. Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus.
Traul KA; Stephens R; Gerber P; Peterson WD
Int J Cancer; 1977 Aug; 20(2):247-55. PubMed ID: 197026
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity.
Thorley-Lawson DA; Geilinger K
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5307-11. PubMed ID: 6254073
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of Epstein-Barr virus gene expression by other herpesviruses.
Kikuta H; Rapp F
Intervirology; 1988; 29(5):281-91. PubMed ID: 2848780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
